Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Omair Husain

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Schizophrenia Bulletin Open|August 15, 2024
Add-on Sodium Benzoate and <i>N</i>-Acetylcysteine in Patients With Early Schizophrenia Spectrum Disorder: A Multicenter, Double-Blind, Randomized Placebo-Controlled Feasibility TrialMuhammad Omair Husain, Imran Bashir Chaudhry, Ameer B Khoso, et al.
Brain, Behavior, and Immunity|November 4, 2023
A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB studyInti Qurashi, Imran B Chaudhry, Ameer B Khoso, et al.
Plos One|December 23, 2025
Adaptation and evaluation of a digital dialectical behaviour therapy for youth at clinical high risk for psychosis: A protocol for a feasibility randomized controlled trialThea Lynne Hedemann, Yun Lu, Sofia Campitelli, et al.
The Lancet. Psychiatry|May 24, 2020
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trialMuhammad Ishrat Husain, Imran B Chaudhry, Ameer B Khoso, et al.
JAMA Network Open|September 2, 2025
Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive Disorder: A Randomized Clinical TrialMuhammad Ishrat Husain, Zahra Nigah, Sami Ul Haque Ansari, et al.
BMC Medicine|July 31, 2023
A culturally adapted manual-assisted problem-solving intervention (CMAP) for adults with a history of self-harm: a multi-centre randomised controlled trialNusrat Husain, Tayyeba Kiran, Imran Bashir Chaudhry, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 27, 2026
Guidelines for the prevention of psychosis from the World Federation of Societies of Biological Psychiatry (WFSBP) and EPI CanadaMarco Solmi, Christoph U Correll, Tommaso Boldrini, et al.
Plos One|September 21, 2023
Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocolSri Mahavir Agarwal, Joel Dissanayake, Ofer Agid, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|November 18, 2023
The Toronto Adolescent and Youth Cohort Study: Study Design and Early Data Related to Psychosis Spectrum Symptoms, Functioning, and SuicidalityKristin Cleverley, George Foussias, Stephanie H Ameis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2026
Assessment of noninvasive quantification of [<sup>18</sup>F]SynVesT-1 with simplified reference tissue model 2 in an adolescent and youth cohortCarme Uribe, Lucas Narciso, Sang Soo Cho, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Schizophrenia Bulletin Open|August 15, 2024
Add-on Sodium Benzoate and <i>N</i>-Acetylcysteine in Patients With Early Schizophrenia Spectrum Disorder: A Multicenter, Double-Blind, Randomized Placebo-Controlled Feasibility TrialMuhammad Omair Husain, Imran Bashir Chaudhry, Ameer B Khoso, et al.
Brain, Behavior, and Immunity|November 4, 2023
A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB studyInti Qurashi, Imran B Chaudhry, Ameer B Khoso, et al.
Plos One|December 23, 2025
Adaptation and evaluation of a digital dialectical behaviour therapy for youth at clinical high risk for psychosis: A protocol for a feasibility randomized controlled trialThea Lynne Hedemann, Yun Lu, Sofia Campitelli, et al.
The Lancet. Psychiatry|May 24, 2020
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trialMuhammad Ishrat Husain, Imran B Chaudhry, Ameer B Khoso, et al.
JAMA Network Open|September 2, 2025
Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive Disorder: A Randomized Clinical TrialMuhammad Ishrat Husain, Zahra Nigah, Sami Ul Haque Ansari, et al.
BMC Medicine|July 31, 2023
A culturally adapted manual-assisted problem-solving intervention (CMAP) for adults with a history of self-harm: a multi-centre randomised controlled trialNusrat Husain, Tayyeba Kiran, Imran Bashir Chaudhry, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 27, 2026
Guidelines for the prevention of psychosis from the World Federation of Societies of Biological Psychiatry (WFSBP) and EPI CanadaMarco Solmi, Christoph U Correll, Tommaso Boldrini, et al.
Plos One|September 21, 2023
Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocolSri Mahavir Agarwal, Joel Dissanayake, Ofer Agid, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|November 18, 2023
The Toronto Adolescent and Youth Cohort Study: Study Design and Early Data Related to Psychosis Spectrum Symptoms, Functioning, and SuicidalityKristin Cleverley, George Foussias, Stephanie H Ameis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2026
Assessment of noninvasive quantification of [<sup>18</sup>F]SynVesT-1 with simplified reference tissue model 2 in an adolescent and youth cohortCarme Uribe, Lucas Narciso, Sang Soo Cho, et al.
Pageof 3